Daiwa Adjusts Price Target on Intuitive Surgical to $630 From $550, Maintains Outperform Rating
Barclays Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $684
BTIG Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $622
BTIG Reaffirms Their Buy Rating on Intuitive Surgical (ISRG)
Barclays Keeps Their Buy Rating on Intuitive Surgical (ISRG)
Intuitive Surgical's Strong Performance and Growth Prospects Earn Buy Rating
Intuitive Surgical's Growth Priced In: Hold Rating Amid Limited Upside Potential
A Quick Look at Today's Ratings for Intuitive Surgical(ISRG.US), With a Forecast Between $650 to $700
Raymond James Maintains Outperform on Intuitive Surgical, Raises Price Target to $688
Intuitive Surgical (ISRG) Gets a Hold From Evercore ISI
A Quick Look at Today's Ratings for Intuitive Surgical(ISRG.US), With a Forecast Between $622 to $711
Intuitive Surgical Is Maintained at Overweight by JP Morgan
Intuitive Surgical Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Elevance Health (ELV), Intuitive Surgical (ISRG) and Walgreens Boots Alliance (WBA)
RBC Capital Keeps Their Buy Rating on Intuitive Surgical (ISRG)
Wells Fargo Reaffirms Their Buy Rating on Intuitive Surgical (ISRG)
Jefferies Adjusts Price Target on Intuitive Surgical to $582 From $575, Maintains Hold Rating
Goldman Sachs Adjusts Price Target on Intuitive Surgical to $637 From $604, Maintains Buy Rating
Raymond James Adjusts Price Target on Intuitive Surgical to $688 From $560, Maintains Outperform Rating
Citigroup Adjusts Price Target on Intuitive Surgical to $711 From $640, Maintains Buy Rating